Fresh Tracks Therapeutics Other Assets

Fresh Tracks Therapeutics (FRTX) currently reports a other assets of $0 as of December 2023. That compares with $64K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Fresh Tracks Therapeutics's other assets history and peer comparisons.

Fresh Tracks Therapeutics's other assets decreased from $64K to $0 — a 100.0% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fresh Tracks Therapeutics reported $0 in other assets as of December 2023. That compares with $64K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fresh Tracks Therapeutics, and consider following FRTX for alerts when major investors trade the stock.

Fresh Tracks Therapeutics is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FRTX with unrelated industries.